A Controlled Assessment of Propranolol in the Treatment of Neuroleptic-induced Akathisia

Overview

Journal Br J Psychiatry

Publisher Cambridge University Press

Specialty Psychiatry

Date 1986 Jul 1

PMID 2877708

Citations 14

Authors

L Adler

B Angrist

E Peselow

J Corwin

R Maslansky

J Rotrosen

Affiliations

Soon will be listed here.

Abstract

Twelve patients with neuroleptic-induced akathisia were treated in a randomised, double-blind, cross-over design with propranolol and matching placebo. Propranolol caused significant decrements in both subjective and objective ratings of akathisia, but not in anxiety scores. This confirms prior findings of the efficacy of propranolol in akathisia induced by neuroleptic treatment.

Citing Articles

Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-Analysis.

Gerolymos C, Barazer R, Yon D, Loundou A, Boyer L, Fond G JAMA Netw Open. 2024; 7(3):e241527.

PMID: 38451521 PMC: 10921255. DOI: 10.1001/jamanetworkopen.2024.1527.

Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Neuropsychopharmacol Rep. 2021; 41(3):266-324.

PMID: 34390232 PMC: 8411321. DOI: 10.1002/npr2.12193.

Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment.

Musco S, McAllister V, Caudle I Ther Adv Psychopharmacol. 2020; 10:2045125320937575.

PMID: 32922732 PMC: 7457694. DOI: 10.1177/2045125320937575.

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study.

Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T Neuropsychiatr Dis Treat. 2018; 14:3179-3184.

PMID: 30538475 PMC: 6257366. DOI: 10.2147/NDT.S184081.

Management of common adverse effects of antipsychotic medications.

Stroup T, Gray N World Psychiatry. 2018; 17(3):341-356.

PMID: 30192094 PMC: 6127750. DOI: 10.1002/wps.20567.